Comparison Table: Amyloid Beta-Directed Antibodies for Alzheimer's Disease (online only)

The Medical Letter on Drugs and Therapeutics

ONLINE
ONLY
ARTICLE

March 30, 2026

View Complete Issue Table of Contents 2019

PDF: US English

Disclosures & Objectives Disclosures & Objectives

Show Related Terms Hide Related Terms

Take CME Exam

View Complete Issue

Send Article Feedback

Disclosures

Principal Faculty

Jean-Marie Pflomm, Pharm.D., Editor in Chief has disclosed no relevant financial relationships.

Additional Contributor(s)

Brinda M. Shah, Pharm.D., Consulting Editor has disclosed no relevant financial relationships.

Objective(s)

Upon completion of this activity, the participant will be able to:

Explain the current approach to the management of Alzheimer's disease dementia and mild cognitive impairment.
Discuss the drugs available for treatment of Alzheimer's disease dementia and other dementias and compare them based on their efficacy, dosage and administration, potential adverse effects, and drug interactions.
Determine the most appropriate therapy given the clinical presentation of an individual patient with Alzheimer's disease dementia or mild cognitive impairment.

Select a term to see related articles Alzheimer's disease dementia donanemab Kisunla Lecanemab Leqembi

Med Lett Drugs Ther. 2026 Mar 30;68(1751):e59-60 doi:10.58347/tml.2026.1751d

View the Comparison Table: Amyloid Beta-Directed Antibodies for Alzheimer's Disease

Download PDF: US English

Important Copyright and Disclaimer Message: The Medical Letter® publications are protected by US and international copyright laws. Forwarding, copying, or any distribution of this material without permission to a nonsubscriber is prohibited. Sharing a password with a nonsubscriber or otherwise making the contents of this site available to third parties is prohibited. By accessing and reading the attached content I agree to comply with US and international copyright law and these terms and conditions of The Medical Letter, Inc.

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.